Propanc Biopharma Invests $100 Million in Crypto, Signaling Growing Institutional Trust

Nasdaq-listed Propanc Biopharma has taken a significant step into the world of cryptocurrency by securing up to $100 million specifically for digital asset purchases. This innovative move marks one of the most prominent entries by a publicly-traded biopharmaceutical company into the emerging market, potentially setting a new standard for healthcare companies exploring alternative investment strategies. 📈 Experts attribute this decision to Propanc’s focus on oncology research and the burgeoning cryptocurrency market. 🤝 💰 )